Chongqing DT Fund made its first large-amount investment, for example, pumping US$10M into Chongqing Porton Fine Chemicals Co., Ltd. With this funding, Porton can expand its production scale aggressively.

Chongqing DT Fund made its first large-amount investment, for example, pumping US$10M into Chongqing Porton Fine Chemicals Co., Ltd. With this funding, Porton can expand its production scale aggressively.

Reportedly, as a leading investment institution in China, the Shanghai-based DT Capital Partners, joined hands with Chongqing Venture Capital Guidance Fund last year and established Chongqing DT Fund with a total size of RMB500M, focusing on the investment in technology sectors such as clean-tech, energy and pharmaceutical enterprises.

As a leading pharmaceutical outsourcing company in China, Porton has quite a few dealings with top pharmaceutical enterprises from the United States and Belgium. Today, it is building a state-of-the-art production base for medical raw materials in Changshou Chemical Park, to satisfy the demand from high-end customers with its most advanced technologies and processes.